Literature DB >> 15629783

Suppression of hepatitis C virus replicon by TGF-beta.

Takayuki Murata1, Takayuki Ohshima, Masashi Yamaji, Masahiro Hosaka, Yusuke Miyanari, Makoto Hijikata, Kunitada Shimotohno.   

Abstract

Hepatitis C virus (HCV) is one of the major causative agents of liver diseases, such as liver inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma. Using an efficient HCV subgenomic replicon system, we demonstrate that transforming growth factor-beta (TGF-beta) suppresses viral RNA replication and protein expression from the HCV replicon. We further show that the anti-viral effect of this cytokine is associated with cellular growth arrest in a manner dependent on Smad signaling, not mitogen-activated protein kinase (MAPK) signaling. These results suggest a novel insight into the mechanisms of liver diseases caused by HCV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629783     DOI: 10.1016/j.virol.2004.10.036

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  28 in total

1.  Transforming growth factor beta enhances respiratory syncytial virus replication and tumor necrosis factor alpha induction in human epithelial cells.

Authors:  Kelly L McCann; Farhad Imani
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

2.  Activation of TGF-β1 promoter by hepatitis C virus-induced AP-1 and Sp1: role of TGF-β1 in hepatic stellate cell activation and invasion.

Authors:  Lance D Presser; Steven McRae; Gulam Waris
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

3.  FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.

Authors:  Updesh Dixit; Ashutosh K Pandey; Zhihe Liu; Sushil Kumar; Matthew B Neiditch; Kenneth M Klein; Virendra N Pandey
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

4.  Identification and evaluation of anti hepatitis C virus phytochemicals from Eclipta alba.

Authors:  Dinesh Manvar; Mahesh Mishra; Suriender Kumar; Virendra N Pandey
Journal:  J Ethnopharmacol       Date:  2012-09-28       Impact factor: 4.360

5.  Modulation of HCV replication and translation by ErbB3 binding protein1 isoforms.

Authors:  Priya Mishra; Updesh Dixit; Ashutosh K Pandey; Alok Upadhyay; Virendra N Pandey
Journal:  Virology       Date:  2016-10-19       Impact factor: 3.616

6.  A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression.

Authors:  Pelagia Foka; Alexios Dimitriadis; Eleni Kyratzopoulou; Dionysios A Giannimaras; Stefania Sarno; George Simos; Urania Georgopoulou; Avgi Mamalaki
Journal:  Cell Mol Life Sci       Date:  2014-04-10       Impact factor: 9.261

7.  Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.

Authors:  Robert Flisiak; Jerzy Jaroszewicz; Tadeusz W Lapinski; Iwona Flisiak; Danuta Prokopowiczi
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

8.  Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.

Authors:  Fang Zhang; Catherine Sodroski; Helen Cha; Qisheng Li; T Jake Liang
Journal:  Gastroenterology       Date:  2016-09-30       Impact factor: 22.682

9.  Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells.

Authors:  Yuki Nishimura-Sakurai; Naoya Sakamoto; Kaoru Mogushi; Satoshi Nagaie; Mina Nakagawa; Yasuhiro Itsui; Megumi Tasaka-Fujita; Yuko Onuki-Karakama; Goki Suda; Kako Mishima; Machi Yamamoto; Mayumi Ueyama; Yusuke Funaoka; Takako Watanabe; Seishin Azuma; Yuko Sekine-Osajima; Sei Kakinuma; Kiichiro Tsuchiya; Nobuyuki Enomoto; Hiroshi Tanaka; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2009-12-12       Impact factor: 7.527

10.  The FUSE binding protein is a cellular factor required for efficient replication of hepatitis C virus.

Authors:  Zhengbin Zhang; Dylan Harris; Virendra N Pandey
Journal:  J Virol       Date:  2008-04-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.